Bayer faces second trial over alleged Roundup cancer risk

Bayer AG is set to face a second U.S. jury over allegations that its popular glyphosate-based weed killer Roundup causes cancer, six months after the company's share price was rocked by a $289 million verdict in California state court.

https://ift.tt/2VavMeK support@endlesssupplies.biz (Endless Supplies .Biz) February 24, 2019 at 07:50AM